ON THIS PAGE: You will find information about how many people are diagnosed with this type of tumor each year and some general survival information. Remember, survival rates depend on several factors. To see other pages, use the menu on the side of your screen.
A primary adrenal gland tumor is very uncommon, and exact statistics are not available for this type of tumor in the United States. It is estimated that approximately 300-500 adults in the United States are diagnosed each year with adrenal cortical cancer. This type of cancer is much less common than an adrenal adenoma, a benign tumor that is more common for middle-aged and older adults. The average age of a person diagnosed with an adrenal gland tumor is 46; however, these tumors can occur at any age. More women than men tend to be diagnosed with adrenal gland tumors.
The five-year survival rate is the percentage of people who survive at least five years after the cancer is found. The five-year survival rate of people with an adrenal cortical cancer depends on different factors, including the extent (or stage) of cancer at the time it is diagnosed, If the cancer is located only in the adrenal gland, the five-year relative survival rate is 65%. If the cancer has spread to nearby tissue or the regional lymph nodes, the five-year survival rate is 44%. If the cancer has spread to a distant part of the body, the five-year survival rate is 7%. Other factors that affect survival include the age of the patient and whether the tumor produces hormones.
Statistics should be interpreted with caution. These estimates are based on data from thousands of people with this type of tumor in the United States, so the actual risk for a particular individual may be different. Because the survival statistics are measured in five-year intervals, they may not represent advances made in the treatment or diagnosis of this cancer. It is not possible to tell a person how long he or she will live with an adrenal gland tumor. Learn more about understanding statistics.
Statistics adapted from the American Cancer Society and A Patient’s Guide to Adrenocortical Cancer from the University of Michigan Comprehensive Cancer Center.
To continue reading this guide, use the menu on the left side of your screen to choose another section.